Literature DB >> 23020595

Origin of Swedish hemophilia A mutations.

C Halldén1, D Nilsson, T Säll, C Lind-Halldén, A C Lidén, R Ljung.   

Abstract

BACKGROUND: Hemophilia A (HA) has a high level of variation within the disease class, with more than 1000 mutations being listed in the HAMSTeRS database. At the same time a number of F8 mutations are present in specific populations at high frequencies.
OBJECTIVES: The simultaneous presence of large numbers of rare mutations and a small number of high-frequency mutations raises questions about the origins of HA mutations. The present study was aimed at describing the origins of HA mutations in the complete Swedish population. The primary issue was to determine what proportion of identical mutations are identical by descent (IBD) and what proportion are attributable to recurrent mutation events. The age of IBD mutations was also determined. PATIENTS/
METHODS: In Sweden, the care of HA is centralized, and the Swedish HA population consists of ~ 750 patients from > 300 families (35% severe, 15% moderate, and 50% mild). Identical haplotypes were defined by single-nucleotide polymorphism and microsatellite haplotyping, and the ages of the mutations were estimated with estiage.
RESULTS: Among 212 presumably unrelated patients with substitution mutations, 97 (46%) had mutations in common with other patients. Haplotyping of the 97 patients showed that 47 had IBD mutations (22%) with estimated ages of between two and 35 generations. The frequency of mild disease increased with an increasing number of patients sharing the mutations.
CONCLUSIONS: A majority of the IBD mutations are mild and have age estimates of a few hundred years, but some could date back to the Middle Ages.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2012        PMID: 23020595     DOI: 10.1111/jth.12010

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR.

Authors:  Eric Manderstedt; Rosanna Nilsson; Rolf Ljung; Christina Lind-Halldén; Jan Astermark; Christer Halldén
Journal:  Res Pract Thromb Haemost       Date:  2020-09-07

2.  Identification of Novel miRNAs in the F8 Gene Via Bioinformatics Tools.

Authors:  Halimeh Rezaei; Majid Motovali-Bashi; Sheyda Khalilian
Journal:  Iran J Biotechnol       Date:  2021-04-01       Impact factor: 1.671

3.  Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening.

Authors:  Eric Manderstedt; Rosanna Nilsson; Christina Lind-Halldén; Rolf Ljung; Jan Astermark; Christer Halldén
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

4.  Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients.

Authors:  Chur Woo You; Hee Jo Baek; Sang Kyu Park; Young Shil Park; Ho-Jin Shin; Werner Engl; Srilatha Tangada
Journal:  Blood Res       Date:  2019-09-25

5.  Genetic and Bioinformatic Strategies to Improve Diagnosis in Three Inherited Bleeding Disorders in Bogotá, Colombia.

Authors:  Juliana Lago; Helena Groot; Diego Navas; Paula Lago; María Gamboa; Dayana Calderón; Diana C Polanía-Villanueva
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

6.  Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.

Authors:  Eric Manderstedt; Christina Lind-Halldén; Stefan Lethagen; Christer Halldén
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

7.  Hemophilia management: Huge impact of a tiny difference.

Authors:  Fabienne Kloosterman; Anne-Fleur Zwagemaker; Amal Abdi; Samantha Gouw; Giancarlo Castaman; Karin Fijnvandraat
Journal:  Res Pract Thromb Haemost       Date:  2020-02-28

8.  Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.

Authors:  Nadine G Andersson; Veerle Labarque; Anna Letelier; Maria Elisa Mancuso; Martina Bührlen; Kathelijn Fischer; Mutlu Kartal-Kaess; Minna Koskenvuo; Torben Mikkelsen; Rolf Ljung
Journal:  Hum Mutat       Date:  2020-10-14       Impact factor: 4.878

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.